Transcatheter closure of tubular type patent ductus arteriosus using Amplatzer® ductal occluder II: a case report

Main Article Content

Mulyadi M Djer
Nikmah Salamia Idris
Angelina Angelina

Abstract

Patent ductus arteriosus (PDA) is a common congenital heart disease, accounting for 5-10% of all congenital heart diseases. The incidence of PDA is even higher in preterm neonates, ranging from 20-60%.1-4 Closure of PDA is indicated in all cases, except for duct-dependent congenital heart diseases or PDA with Eisenmenger syndrome.1,5,6 In small asymptomatic PDAs, closure is indicated to prevent the risk of complications, such as endarteritis, endocarditis, aneurysm of ductus arteriosus, or congestive heart failure.1,2,7
In recent years, interventional cardiology has become a gold standard therapy for the majority of PDA cases beyond neonatal age. Since its introduction in 1967, many devices and methods have been developed to allow transcatheter closure of virtually all PDAs, regardless of size or configuration. Nevertheless, the tubular shape (type C) PDA, which has the highest residual shunt rate, still poses a great challenge for the interventionist.8-10 The second generation of Amplatzer® device occluders (ADO II), released in 2007, has been suggested to be effective in closing tubular PDAs.10 The purpose of this study was to report the initial clinical experience using ADO II to close a tubular type PDA in Indonesia.

Article Details

How to Cite
1.
Djer M, Idris N, Angelina A. Transcatheter closure of tubular type patent ductus arteriosus using Amplatzer® ductal occluder II: a case report. PI [Internet]. 30Oct.2013 [cited 21Sep.2019];53(5):291-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/309
Section
Articles
Received 2016-08-21
Accepted 2016-08-21
Published 2013-10-30

References

1. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873-82.
2. Forsey JT, Elmasry OA, Martin RP. Patent arterial duct. Orphanet J Rare Dis. 2009;4:17.
3. Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther. 2007;12:138-46.
4. Gien J. Controversies in the management of patent ductus arteriosus. Neoreviews. 2008;9:477-82.
5. Yarrabolu TR, Rao PS. Transcatheter closure of patent ductus arteriosus. Pediatr Therapeut. 2012;S5:1-8.
6. Tharakan J, Venkateshwaran S. Large patent ductus arteriosus: to close or not to close. Ann Pediatr Cardiol. 2012;5:141–4.
7. Bernstein D. Congenital heart disease. In: Behrman RE, Kliegman RM, Nelson WE, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Pennsylvania: Saunders; 2004. p. 1510-12.
8. Rao PS. Historical aspects of transcatheter treatment of heart disease in children. Pediatr Therapeut. 2012;S5:1-13.
9. Moore JW, Levi DS, Moore SD, Schneider DJ, Berdjis F. Interventional treatment of patent ductus arteriosus in 2004. Catheter Cardiovasc Interv. 2005;64:91–101.
10. Liddy S, Oslizlok P, Walsh KP. Comparison of the results of transcatheter closure of patent ductuc arteriosus with newer amplatzer devices. Catheter Cardiovasc Interv. 2013;82:253-9.
11. Park MK. Pediatric cardiology for practitioners. 5th ed. Philadelphia: Mosby Elsevier; 2008. p. 221-8.
12. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010; 125:1020–30.
13. Djer MM, Putra ST, Ulfa A, Roebiono PS, Rahman MA, Noormanto, et al. Penatalaksanaan penyakit jantung bawaan tanpa bedah. Jakarta: Departemen Kesehatan Republik Indonesia; 2007. p. 11-22
14. Djer MM. Tata laksana penyakit jantung bawaan tanpa operasi. In: Gunardi H, Tehuteru S, Kurniati N, Advani N, Setyanto DB, Wulandari HF, et al., editors. Jakarta: Balai Penerbit IDAI; 2011. p. 131-5.
15. Madiyono B, Rahayuningsih SE, Sukardi R. Penanganan penyakit jantung pada bayi dan anak. Jakarta: Balai Penerbit FKUI; 2008. p. 9-13.
16. Samion H. Interventional treatment of congenital heart disease. In: Putra ST, Djer MM, Roeslani RD, Endyarni B, Yuniar I, editors. Proceedings of management of pediatric heart disease for practitioners: from early detection to intervention; 2009 Nov 8-9; Jakarta, Indonesia. p. 154-9.
17. Chen ZY, Wu LM, Luo YK, Lin CG, Peng YF, Zhen XC, et al. Comparison of long-term clinical outcome between transcatheter Amplatzer occlusion and surgical closure of isolated patent ductus arteriosus. Chin Med J (Engl). 2009;122:1123-7.
18. Venczelova Z, Tittel P, Masura J. The new Amplatzer duct occluder II: when is its use advantageous? Cardiol Young. 2011;21:495–504.
19. Saliba Z, El-Rassi I, Abi-Warde MT, Chehab G. Daou L, Khater D, et al. The Amplatzer duct occluder II: a new device for percutaneous ductus arteriosus closure. J Interv Cardiol. 2009;22:496–502.
20. Karagoz T, Akin A, Ertugrul I, Aykan HH, Alehan D, Ozer S, et al. Closure of the patent ductus arteriosus with the Amplatzer Duct Occluder II: a clinical experience. Acta Cardiol. 2012;67:675-80.
21. Thanopaulos B, Eleftherakis N, Tzannos K, Stefanadis C. Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J. 2008;156:1-6.